
Partnership27 Mar 2024, 01:21 am
Sanofi and Cipla Announce Exclusive Distribution Partnership for CNS Portfolio in India
AI Summary
Sanofi India and Cipla have announced an exclusive partnership where Cipla will distribute and promote Sanofi India's Central Nervous System (CNS) product range in India. Sanofi India will continue to manufacture and imports its CNS products, while Cipla will leverage its network and capabilities to expand access to these treatments. This collaboration is aiming to bring high-quality therapeutic solutions to patients across the country.
Key Highlights
- Sanofi India and Cipla announce exclusive partnership
- Cipla to distribute Sanofi India's CNS product range
- Sanofi India to continue manufacturing and importing CNS products
- Cipla to expand access to these treatments using its network
- Collaboration aims to bring high-quality therapeutic solutions to patients across India